Protein-Protein Interactions, Clustering, and Rheology for Bovine IgG up to High Concentrations Characterized by Small Angle X-Ray Scattering and Molecular Dynamics Simulations-Reference-Cited by-同舟云学术

Protein-Protein Interactions, Clustering, and Rheology for Bovine IgG up to High Concentrations Characterized by Small Angle X-Ray Scattering and Molecular Dynamics Simulations

Published:2020-01 Issue:1 Volume:109 Page:696-708
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Chowdhury Amjad,Guruprasad Geetika,Chen Amy T.,Karouta Carl A.,Blanco Marco A.,Truskett Thomas M.,Johnston Keith P.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. Antibody Society. Antibody therapeutics approved or in regulatory review in the EU or US. Available at: https://www.antibodysociety.org/resources/approved-antibodies/. Accessed December 4, 2019.

2. Chapter one–rational design of liquid formulations of proteins;Manning,2018

3. Antibody and antibody derivatives as cancer therapeutics;Arlotta;Wiley Interdiscip Rev Nanomed Nanobiotechnol,2019

4. Anisotropic contributions to protein–protein interactions;Quang;J Chem Theor Comput,2014

5. Proximity energies: a framework for understanding concentrated solutions;Laue;J Mol Recognit,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody association in solution: cluster distributions and mechanisms;mAbs;2024-04-26

2. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution;Molecular Pharmaceutics;2024-02-22

3. Protein Association in Solution: Statistical Mechanical Modeling;Biomolecules;2023-11-24

4. Characterizing Protein–Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics Simulations;Molecular Pharmaceutics;2023-10-02

5. Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High Concentrations;Molecular Pharmaceutics;2023-05-16